MAPT and Alzheimer disease: In AD, however, aberrant PTMs disrupt tau’s normal function, promoting its misfolding, aggregation, and eventual formation of neurofibrillary tangles (NFTs), which contribute to cytoskeletal destabilization and neuronal loss [193,194].